§ 13F · FUND PROFILE
ARCH Venture Management, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 10Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$24M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | MAZE | MAZE THERAPEUTICS INC | 4.12M | $123M | 18.2% | ±0% |
| 2 | RAPP | RAPPORT THERAPEUTICS INC | 3.73M | $117M | 17.2% | ±0% |
| 3 | VIR | VIR BIOTECHNOLOGY INC | 12.92M | $116M | 17.1% | ±0% |
| 4 | ERAS | ERASCA INC | 7.09M | $115M | 16.9% | −36% |
| 5 | BEAM | BEAM THERAPEUTICS INC | 4.54M | $108M | 16.0% | ±0% |
| 6 | LYEL | LYELL IMMUNOPHARMA INC | 3.25M | $65M | 9.6% | +18% |
| 7 | GENB | GENERATE BIOMEDICINES INC | 1.94M | $24M | 3.6% | NEW |
| 8 | TXG | 10X GENOMICS INC | 218K | $5M | 0.7% | −70% |
| 9 | GOSS | GOSSAMER BIO INC | 8.06M | $3M | 0.4% | ±0% |
| 10 | QTTB | Q32 BIO INC | 320K | $2M | 0.3% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ARCH SIGNAL
AC read
ARCH Venture Management, LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed